Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,266,428
+$118,290 QoQ
Shares Held
8,924
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
#2,246
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M.E. ALLISON & CO., INC. holds $8,411,597 across 9 Drug Manufacturers - General names. JNJ ranks #1 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
8,924 | $2,266,428 | |
| 2 | LLY |
ELI LILLY & Co
|
1,427 | $1,711,586 | |
| 3 | PFE |
Pfizer Inc
|
41,742 | $1,005,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,203 | $925,585 | |
| 5 | ABBV |
AbbVie Inc.
|
2,390 | $601,419 | |
| 6 | AMGN |
Amgen Inc
|
1,644 | $595,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,318 | $479,283 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,633 | $458,993 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,266,428 | 8,924 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $2,148,138 | 8,788 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,818,676 | 8,788 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,645,417 | 8,874 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,111,103 | 7,274 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,206,320 | 7,274 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,012,195 | 6,999 | Shares | Sole | 2025-01-16 | |
| No filing history on record for this holder in this stock. | ||||||